SGLT2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis (EDKA) in Patients With Underlying Risk Factors.

IF 2.3 4区医学 Q3 PHARMACOLOGY & PHARMACY

Annals of Pharmacotherapy Pub Date : 2024-11-26 DOI:10.1177/10600280241294060

Paul Joseph Solinsky, Amy Holstege, Glen Burnie

引用次数: 0

查看原文本刊更多论文

有潜在风险因素的患者因 SGLT2 抑制剂诱发的血糖性糖尿病酮症酸中毒（EDKA）。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Annals of Pharmacotherapy 医学-药学

CiteScore

5.70

自引率

0.00%

发文量

166

审稿时长

3-8 weeks

期刊介绍： Annals of Pharmacotherapy (AOP) is a peer-reviewed journal that advances pharmacotherapy throughout the world by publishing high-quality research and review articles to achieve the most desired health outcomes.The articles provide cutting-edge information about the most efficient, safe and cost-effective pharmacotherapy for the treatment and prevention of various illnesses. This journal is a member of the Committee on Publication Ethics (COPE). Average time from submission to first decision: 14 days